| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $1,007,206 | 1 | 50 |
Sells | $652,003 | 1 | 50 |
| Aharon Gil | director | 1 | $1.01M | 0 | $0 | $1.01M |
| MASIMO CORP | 10 percent owner | 0 | $0 | 1 | $652,003 | $-652,003 |
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Over the last 12 months, insiders at NeurAxis, Inc. have bought $1.01M and sold $652,003 worth of NeurAxis, Inc. stock.
On average, over the past 5 years, insiders at NeurAxis, Inc. have bought $1.01M and sold $652,003 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Aharon Gil (director) — $1.01M.
The last purchase of 286,138 shares for transaction amount of $1.01M was made by Aharon Gil (director) on 2025‑12‑23.
| 2025-12-23 | Aharon Gil | director | 286,138 2.097% | $3.52 | $1.01M | +35.20% | ||
| 2025-07-01 | Sale | MASIMO CORP | 10 percent owner | 289,779 1.3575% | $2.25 | $652,003 | +15.55% |
| Increased Positions | 9 | +42.86% | 839,216 | +103.72% |
| Decreased Positions | 7 | -33.33% | 75,779 | -9.37% |
| New Positions | 5 | New | 551,251 | New |
| Sold Out Positions | 5 | Sold Out | 62,347 | Sold Out |
| Total Postitions | 23 | +9.52% | 2M | +94.36% |